Exposure to disulfiram and incidence of parkinsonism
These results support the hypothesis that disulfiram may cause parkinsonism. Clinicians and drug regulatory agencies should consider parkinsonism when assessing the risks and benefits of disulfiram use.
Authors
- Samuel M. Goldman (ORCID: https://orcid.org/0000-0002-3039-9927)
- Elena Strippoli (ORCID: https://orcid.org/0000-0001-7120-9205)
- Paul D. Blanc (ORCID: https://orcid.org/0000-0001-9043-175X)
- Angelo d’Errico (ORCID: https://orcid.org/0000-0003-3171-413X)
Institutions
- University of California, San Francisco (US)
- Torino e-district (IT)
Publication Details
- Journal
- Journal of Occupational Medicine and Toxicology
- Published
- 2025-03-12
- DOI
- https://doi.org/10.1186/s12995-025-00454-9
- Citations
- 3
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.17